Hormone Therapy Linked to CV Risk During Gender Transition Hormone Therapy Linked to CV Risk During Gender Transition

Transgender hormone therapy is associated with an increased risk for MI, stroke, and venous thromboembolism, underscoring the importance of patient counseling and close monitoring in this population.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news